Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Empowering Frontline Care in IBS-C: Moving Beyond OTC Therapies
May 1, 2026
Unknown duration
The Right Fit: Personalizing COPD Device Selection Across the Patient Journey
May 1, 2026
Unknown duration
When Monotherapy Fails in Depression: An Evidence-Based Update
Apr 30, 2026
Unknown duration
From Symptoms to Success: Real-World Cases in Patient-Centered IBS-C Care
Apr 29, 2026
Unknown duration
Multidisciplinary Management of Metabolic Dysfunction-Associated Steatohepatitis
Apr 29, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/1/26 |  Empowering Frontline Care in IBS-C: Moving Beyond OTC Therapies | Do you know when to advance patients with IBS-C from over-the-counter to prescription treatments? Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/empowering-frontline-care-ibs-c-moving-beyond-otc-therapies-2026a1000cxp?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 5/1/26 | The Right Fit: Personalizing COPD Device Selection Across the Patient Journey | Optimize patient outcomes by selecting the right inhaler device for the right patient. Credit available for this activity expires: 4/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/right-fit-personalizing-copd-device-selection-across-patient-2026a1000dcc?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/30/26 | When Monotherapy Fails in Depression: An Evidence-Based Update | Next steps for major depressive disorder (MDD): master the latest clinical data on augmentation and switching strategies. Credit available for this activity expires: 4/29/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/when-monotherapy-fails-depression-evidence-based-update-2026a1000d6q?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/29/26 | From Symptoms to Success: Real-World Cases in Patient-Centered IBS-C Care | Dr Brian Lacy discussed the management of constipation-predominant irritable bowel syndrome (IBS-C) in the context of patient cases. Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/symptoms-success-real-world-cases-patient-centered-ibs-c-2026a1000cze?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/29/26 | Multidisciplinary Management of Metabolic Dysfunction-Associated Steatohepatitis | Experts discuss the different roles of clinicians in managing metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/multidisciplinary-management-metabolic-dysfunction-2026a1000d62?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/29/26 | Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions | Do you know how to apply best practices for HER2 testing and identify patients who may benefit from targeted therapies? Join us to learn more! Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-care-her2-mutated-nsclc-evidence-diagnostics-and-2026a1000d6g?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/29/26 | The Mechanisms Behind Rapid-Acting Treatments for Major Depressive Disorder | Explore how rapid-acting therapies transform major depressive disorder (MDD) care--uncover the neurobiology and mechanisms driving faster antidepressant effects. Credit available for this activity expires: [04/27/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanisms-behind-rapid-acting-treatments-major-depressive-2026a1000cld?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/28/26 | Cracking the Code With Coronary Artery Calcium (CAC) | How do you turn your patients' calcium scores into clear, personalized prevention plans? Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-two-cracking-code-coronary-artery-calcium-cac-2026a1000clt?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/27/26 | Cracking the Code: Optimizing Outcomes in All Patients With High-Risk HR+/HER2-Negative Early Breast Cancer | Master assessing high-risk hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC): outsmart recurrence with data-driven precision. Credit available for this activity expires: 04/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cracking-code-optimizing-outcomes-all-patients-high-risk-hr-2026a1000crj?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/24/26 | Breaking the OTC Cycle: Optimizing Prescription Therapy for IBS-C in Everyday Practice | Do you know when to advance patients with IBS-C from over-the-counter to prescription treatments? Credit available for this activity expires: 04/22/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-otc-cycle-optimizing-prescription-therapy-ibs-c-2026a1000bpz?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/23/26 | Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer | Are you confident in identifying the risk for recurrence in early-stage HR-positive, HER2-negative breast cancer? Credit available for this activity expires: [04/21/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/22/26 | Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence | Risk vs Biology: Which carries more weight in the decision to escalate therapy? Credit available for this activity expires: 04/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/22/26 | Beyond the Headlines: A Critical Look at MRA Evidence in HFpEF | Are you up to date on the latest clinical developments for steroidal and nonsteroidal mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF)? Credit available for this activity expires: 04/08/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-headlines-critical-look-mra-evidence-hfpef-2026a1000al7?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/9/26 | Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment | Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC? Credit available for this activity expires: 4/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/8/26 | Biosimilars: What Primary Care Needs to Know About Biosimilars in Practice | Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns. Credit available for this activity expires: 4/7/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003282?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/8/26 | Enhancing Clinical Understanding of Oral SERD-Based Therapies for Patients With ER-Positive/HER2-Negative MBC | Did you know prior CDK4/6 duration may be prognostic for identifying patients more likely to benefit from single-agent oral SERDs? Credit available for this activity expires: 04/07/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/enhancing-clinical-understanding-oral-serd-based-therapies-2026a1000a46?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/3/26 | Maximizing Therapeutic Efficacy Prior to Epilepsy Surgery: Considerations for the Selection of Antiseizure Medications | Optimize every trial: Discover how strategic medication selection clarifies the surgical path and improves patient outcomes before intervention. Credit available for this activity expires: 04/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-therapeutic-efficacy-prior-epilepsy-surgery-2026a10009oz?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/30/26 | Expanding the Actionability of Crucial Biomarkers in Your Community-Based Colorectal Cancer Clinic | Do you know what to test for in your patients with CRC? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/expanding-actionability-crucial-biomarkers-your-community-2026a10009al?ecd=bdc_podcast_libsyn_mscped | — | ||||||
| 3/30/26 | Identifying Suboptimally Managed Erosive Esophagitis in Clinical Practice | Do you know the next best steps for a patient with persistent gastroesophageal reflux disease (GERD) symptoms? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/identifying-suboptimally-managed-erosive-esophagitis-2026a100096o?ecd=bdc_podcast_libsyn_mscped | — | ||||||
| 3/30/26 | Steps for Personalized and Collaborative Decision-Making in HER2-Mutated NSCLC | Get the latest updates on HER2-mutated NSCLC. Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/steps-personalized-and-collaborative-decision-making-her2-2026a10007ur?ecd=bdc_podcast_libsyn_mscped | — | ||||||
| 3/30/26 | The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma | Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | Progressive Familial Intrahepatic Cholestasis: Case From the Community | Learn PFIC genetics, case-based management, and family counseling with Dr Kushner. Credit available for this activity expires: 03/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/progressive-familial-intrahepatic-cholestasis-case-community-2026a100070f?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | Rapid Reports in Dravet Syndrome: Synthesizing Pipeline Developments | A quick take on what's on the horizon for Dravet syndrome treatment Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/rapid-reports-dravet-syndrome-synthesizing-pipeline-2026a10007ux?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/16/26 | Demystifying Bronchiectasis: Rethinking Standards of Care | Bronchiectasis affects up to 500,000 Americans and requires a personalized treatment approach to prevent serious complications. Credit available for this activity expires: 03/13/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/demystifying-bronchiectasis-rethinking-standards-care-2026a10006kz?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/2/26 | Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease | Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Showing 25 of 655
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.